Ampersand Biomedicines’ Post

Argenica Therapeutics Explore essential executive insights into Argenica Therapeutics' recent progress in the Phase 2 trial of ARG-007, focusing on safety and operational efficiency. Read More https://lnkd.in/gbzUzpmj #Biotechnology, #ARG007, #clinicalTrial, #executiveInsights, #strategicAnalysis

Thank you to everyone who joined our webinar on "Nucleic Acid Therapeutics: Successes, Milestones, and Upcoming Innovation." For those who missed it or wish to revisit the discussion, the recording is now available on-demand. Watch it here: https://lnkd.in/g6FyCA_k #nucleicacidtherapeutics #biotechnology #pharmaceuticalresearch #otswebinar

How has M&A impacted WWH? (since April 2022-March 2024) We have single stock exposure to companies that been acquired by #LargeCapPharmaceuticals, including Global Blood Therapeutics, Mirati Therapeutics, Seagen and Turning Point Therapeutics. WWH has held 20 of the 48 acquired public biotech companies through outright exposure and/or our M&A basket (which is regularly adjusted by our analysts). #Healthcare #Biotechnology #GrowthPortfolio You can watch the AGM recording here 👉 https://lnkd.in/eZZw43zW August factsheet: https://lnkd.in/euSDzFT7 Find out more here: https://lnkd.in/eRNN7UZ6 Investments involve risks. The value of investments and income derived from them may go down as well as up and you may not receive back all the money which you invest. Past performance is no guarantee of future performance.

🚀 Discover the latest achievements & breakthroughs from our #Portfolio companies. #Ysiosportfolio

Discover how Watershed Bio and Violet Therapeutics collaborated to build a custom RABID-seq pipeline in our latest case study summary. And access the full study on our website: https://lnkd.in/eTW_g7PE #watershedbio #bioinformatics #dataanalytics

FibroBiologics is set to join the Russell 2000® Index effective July 1, 2024, according to a preliminary list of additions. This milestone reflects our growth and commitment to developing novel therapeutics using fibroblasts. Joining the #Russell2000 marks a significant step in increasing our visibility in the investment community and enhancing shareholder value. For more: https://bit.ly/4cHC6ST #Biotechnology #InvestmentGrowth

Alberto Loche and I had the great honor to convene the McKinsey CGT expert panel at the #jpm2024 conference with Lynelle Hoch (BMS), Jak Knowles (Affini-T Therapeutics), Fabian Gerlinghaus (Cellares), Peter Olagunju (March Biosciences), and Cindy Perettie (Kite, A Gilead Company). Thanks all for such an insightful discussion and stay tuned for more insights coming out soon! #biotech #CGT #innovation #mckinseyinsights

#powerofsharing 🥁Insightful resharing of CGT market updates 🙏Serving Cell and Gene therapy market is a spectacular opportunity and I’m already vitnessing the potential opportunities. 🩺No doubt, being focused on establishing co creative strategies & ecosystem puts patients safely as priority and that’s clearly one of my top 5 strategies 🧬The cell and gene therapy market in India, Southeast Asia, Taiwan, and Australia is poised for explosive growth over the next five years. 📍With innovations in personalized medicine, rising healthcare investments, and supportive regulations, this region is emerging as a biotech powerhouse. 📍Market size is expected to substantially soar, driven by a surge in clinical trials and strategic collaborations. 📍By 2029, the market will witness significant expansion, solidifying its status as a premier hub for cutting-edge therapies and investment opportunities. ✍️Stay tuned for more updates and insights ✍️ #️⃣ #singleusesupport #PioneeringBiopharma #singleuse #singleusebags #advancedtherapies #mabs #biopharma #bioprocessing #biopharmaceuticals #bioprocess #bioproduction #vaccines #genetherapy #mrna #mrnavaccines #celltherapy #cellandgenetherapy #celltherapymanufacturing #celltherapies #biosimilars #cancertherapy #aav #viralvectors #clinicaltrials #cmo #cdmo #pDNA #pharmaexhibition #pharmaexpoindia #cphipmecindia2023 #pharmaevents #pharma #pharmapackaging #patientcentricpackaging #medicaldrugspackaging #pharmacology #pharmtech #pharmaceuticals #pharmanex #indiaexpomart #CPHIIndia #PMECIndia #PharmaEvent #PharmaIndustry #Science #Inventions #PMEC #Noida #BiggestPharmaEvent #India #Delhi #Event #Healthcare #Health #Exhibition #bioprocess #biopharmaexhibition #bioprocessequipment #singleusebags #2Dbags #3Dbags #upstream #downstream #krubakaranctb

Thanks to everyone who joined and asked questions at our seminar with N=1 Collaborative yesterday! Our Chief Technology Officer, David Butler, spoke on a panel of experts about "Control of regulatory starting material quality for oligonucleotide therapeutics". During the talk, David provided insights into the synthesis of phosphoramidites, a systematic approach to categorizing phosphoramidite impurities, and analytical techniques for purity and impurities characterization and measurement of amidites used in N=1 oligonucleotides. Did you miss it? Don't worry, you can catch up with the recording on-demand via the link below. 👇 https://loom.ly/4n4G4Kw #Oligonucleotides #PharmaEvent #CDMO

Understand the potential of the difficult-to-express protein market driven by the surging demand for recombinant proteins. Learn more about how innovative therapeutics, exemplified by Amgen Inc.'s Prolia, are shaping the landscape of medical solutions. Dive deeper into the protein market dynamics: https://lnkd.in/gDq7dX22 . . . #difficulttoexpressprotein #recombinantproteins #medicalinnovation #marketgrowth #biotechnology #tbrc #thebusinessresearchcompany #marketresearch #marketintelligence